Clinical pharmacology: Current innovations and future challenges

Area of Science:

• Clinical pharmacology
• Drug development
• Translational research

Background:

• Clinical pharmacology studies drugs in humans, from initial trials to large-scale assessments.
• Recent innovations may significantly alter future drug development processes.

Purpose of the Study:

• To review recent innovations poised to revolutionize drug development.
• To provide recommendations for future challenges in clinical pharmacology.

Main Methods:

• Review of emerging technologies and methodologies in drug development.
• Analysis of innovations in healthy volunteer studies and clinical trial designs.
• Exploration of precision medicine's role in identifying targets and patient stratification.

Main Results:

• Emerging technologies like artificial intelligence (AI), machine learning, and internet-based trials can enhance drug development.
• Alternative clinical trial designs (e.g., pragmatic, platform trials) are gaining traction alongside randomized controlled trials (RCTs).
• Precision medicine advancements will aid in identifying new therapeutic targets and at-risk patient populations.

Conclusions:

• Rigorous preliminary data on drug mechanisms and robust study designs are fundamental.
• Collaboration, data transparency, and enhanced stakeholder engagement are crucial for advancing clinical pharmacology.
• Future drug development will likely integrate novel technologies and personalized approaches.